Skip to main content
. 2015 Nov 6;13(11):6759–6773. doi: 10.3390/md13116759

Table 2.

Anti HBV activity and cytotoxicity of Compound 1, 2 and entecavir in HepG2.2.15.7 cells.

Compound EC50 a (µM) CC50 b (µM) Selectivity c Index
Compound 1 0.23 ± 0.07 4.19 ± 0.12 18.2
Compound 2 0.80 ± 0.34 10.26 ± 3.69 12.8
Entecavir 0.021 ± 0.003 >100 >4761

a Fifty percent effective concentration based on the inhibition of the HBV viral DNA release; b Fifty percent cytotoxicity concentration based on the reduction of cell viability; c Selectivity index (CC50/EC50).